Monte Rosa Therapeutics (GLUE) drew fresh attention after reporting strong interim Phase 1 results for MRT-8102, its NEK7-directed molecular glue degrader. The data showed rapid, sustained reductions ...
Marin just simultaneously experienced two natural phenomena: extreme king tides accompanied by wet storms. Unless wildly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback